The Osseoflex SB is the company’s latest sterrable vertebral compression fractures product.
Osseon Therapeutics develops and commercializes medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures.
The company is headquartered in Santa Rosa, Calif.
Related Articles on FDA Clearances:
SpineSmith Receives FDA Clearance for Plating System
Roche Receives FDA Clearance for Blood Glucose Monitor
Respiratory Motion Receives FDA Clearance for Respiratory Monitoring System
